Back
American Express Co. Vs. Akero Therapeutics Industry Stock Comparison
Buy
64
AXP
American Express Co.
Last Price:
$305.57
Seasonality Move:
-0.05%
Sell
46
AKRO
Akero Therapeutics
Last Price:
$49.43
Seasonality Move:
26.87%
Buy
64
American Express Co. (AXP)
is a Buy
Is American Express Co. a Buy, Sell or Hold?
-
The current American Express Co. [AXP] share price is $307.73. The Score for AXP is 64, which is 28% above its historic median score of 50, and infers lower risk than normal.
-
AXP is currently trading in the 60-70% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Sell
46
Akero Therapeutics (AKRO)
is a Sell
Is Akero Therapeutics a Buy, Sell or Hold?
-
The current Akero Therapeutics [AKRO] share price is $50.09. The Score for AKRO is 46, which is 8% below its historic median score of 50, and infers higher risk than normal.
-
AKRO is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
AXP Stock Price Chart
What is American Express Co.'s stock price today?
-
The American Express Co. share price today is $307.73Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and AXP is experiencing buying pressure, which is a positive indicator for future bullish movement.
AKRO Stock Price Chart
What is Akero Therapeutics's stock price today?
-
The Akero Therapeutics share price today is $50.09Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and AKRO is experiencing buying pressure, which is a positive indicator for future bullish movement.
AXP Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | -1.62 | Sell |
Relative Strength Index (14 RSI): | 54.49 | Buy |
Chaikin Money Flow: | 1937819 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (297.98 - 312.82) | Buy |
Bollinger Bands (100): | (267.23 - 312.43) | Buy |
AKRO Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | -0.62 | Sell |
Relative Strength Index (14 RSI): | 49.73 | Sell |
Chaikin Money Flow: | 1066365 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (48.52 - 52.32) | Sell |
Bollinger Bands (100): | (40.84 - 53.12) | Buy |
AXP Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 299.8 | Buy |
20-day SMA: | 302.84 | Buy |
50-day SMA: | 306.4 | Buy |
200-day SMA: | 292.69 | Buy |
8-day EMA: | 302.39 | Buy |
20-day EMA: | 303.45 | Buy |
50-day EMA: | 302.56 | Buy |
200-day EMA: | 286.66 | Buy |
AKRO Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 49.75 | Buy |
20-day SMA: | 49.82 | Buy |
50-day SMA: | 52.04 | Sell |
200-day SMA: | 41.79 | Buy |
8-day EMA: | 49.35 | Buy |
20-day EMA: | 49.93 | Buy |
50-day EMA: | 49.95 | Buy |
200-day EMA: | 42.97 | Buy |
American Express Co. Earnings Growth & AXP Earnings Dates
-
Analysts estimate an earnings increase this quarter of $0.71 per share, an increase next quarter of $0.55 per share, an increase this year of $1.76 per share, and an increase next year of $1.98 per share.
Akero Therapeutics Earnings Growth & AKRO Earnings Dates
-
Analysts estimate an earnings increase this quarter of $0.02 per share, a decrease next quarter of $0.13 per share, an increase this year of $0.23 per share, and a decrease next year of $0.61 per share.
American Express Co. Technical Analysis
Aug 1 | Aug 4 | Aug 5 | Aug 6 | Aug 7 | Aug 8 | Aug 11 | Aug 12 | Aug 13 | Aug 14 | |
---|---|---|---|---|---|---|---|---|---|---|
Aug | ||||||||||
01 | 04 | 05 | 06 | 07 | 08 | 11 | 12 | 13 | 14 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
Akero Therapeutics Technical Analysis
Aug 1 | Aug 4 | Aug 5 | Aug 6 | Aug 7 | Aug 8 | Aug 11 | Aug 12 | Aug 13 | Aug 14 | |
---|---|---|---|---|---|---|---|---|---|---|
Aug | ||||||||||
01 | 04 | 05 | 06 | 07 | 08 | 11 | 12 | 13 | 14 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |